ArticleMolecular therapy : the journal of the American Society of Gene Therapy2021

Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy.

Cristina R Reschke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.